Sun Pharma best among pharma stocks, Biocon may hit Rs 845: Bose

Rajat Bose of rajatkbose.com told CNBC-TV18, "I have three pharma stocks - Divis Laboratories, Sun Pharmaceutical Industries and Biocon. Out of these three, I would rate Sun Pharma as the best chart. Sun Pharma yesterday did pretty well and it is actually shows that further upside could be very much likely here. I have kept a modest target of Rs 842 given the kind of momentum Sun Pharma tends to acquire. I would put a stop loss at Rs 817. Its chart suggests that medium-term prospects looks pretty bright." "The fundamentals and even the technical charts of Biocon are supporting that kind of fundamental story. Biocon continues to move up, I have suggested this stock for medium to long term purchase to my clients. I am looking at much higher targets. However, for the day Rs 838 and 845 would be the two good targets and put a stop loss below Rs 814," he said."Divis Laboratories is acquiring momentum and there is every possibility that the stock would continue to maintain that tempo that it showed yesterday. It not just a bullish overture, it is real strength, so target is Rs 1,228, it is a day target and have kept a stop loss at Rs 1,174. It tends to be pretty volatile but still I think it would manage to move up on the upside."